# PROVISIONAL PATENT APPLICATION DRAFT SPECIFICATION

**TITLE OF INVENTION**: SYSTEM AND METHOD FOR TRIANGULATED ADVERSARIAL MULTI-AGENT HYPOTHESIS EVALUATION, AUTOMATED CONFLICT-OF-INTEREST AUDITING, AND DETERMINISTIC SENSITIVITY-WEIGHTED EVIDENCE SYNTHESIS

**INVENTOR**: Vadim Koenen  
**DATE OF PREPARATION**: July 25, 2026  

---

## 1. ABSTRACT
A computer-implemented system and method for evaluating complex scientific, clinical, and technological hypotheses using a Triangulated Adversarial Multi-Agent Synthesis (TAES) pipeline. The system retrieves primary literature from distributed databases (e.g., PubMed, CrossRef) and concurrently executes three specialized asynchronous software agents: (a) a Proponent Agent optimized to harvest statistical efficacy markers and cohort sizes; (b) a Falsifier/Skeptic Agent incentivized to identify cohort size deficits, non-randomized trial designs, and financial conflict-of-interest declarations; and (c) a Synthesizer Agent executing a deterministic GRADE certainty algorithm to calculate a dynamic Net Truth Certainty Index (%). The system further provides a real-time sensitivity graph enabling parameter-driven re-weighting of primary evidence.

---

## 2. BACKGROUND OF THE INVENTION
Existing Retrieval-Augmented Generation (RAG) software applications process user queries by returning single-pass generative summaries. Such systems suffer from three primary technical limitations:
1. **Uncontrolled Hallucinated Attribution**: Generative language models frequently misattribute quotes or claim statistical significance where none exists.
2. **Equal-Weight Processing**: Standard RAG architectures treat small retrospective observational cohorts ($N < 20$) with equal weight to multi-center randomized controlled trials ($N > 5,000$).
3. **Absence of Adversarial Stress-Testing**: Prior systems lack explicit loss functions designed to actively attempt to invalidate user hypotheses using counter-evidence.

The present invention solves these technical problems through a multi-agent adversarial architecture paired with a deterministic scoring engine.

---

## 3. SUMMARY OF THE INVENTION & NOVEL CLAIMS

### Claim 1: The TAES Architecture
A method comprising:
* Receiving a natural language target hypothesis via a digital user interface;
* Querying one or more remote academic databases to retrieve a plurality of primary document metadata objects;
* Concurrently instantiating a Proponent Agent task and a Skeptic Agent task, wherein:
  * The Proponent Agent evaluates positive primary outcome measures ($p < 0.05$) and aggregates total patient sample size ($\sum N$);
  * The Skeptic Agent scans metadata objects for risk factors including non-randomized study design, small cohort size ($N < \text{threshold}$), and author conflict-of-interest (COI) declarations;
* Synthesizing outputs from said Proponent Agent and Skeptic Agent using a Synthesizer Agent.

### Claim 2: Deterministic Certainty Scoring Algorithm
The method of Claim 1, wherein said Synthesizer Agent calculates a Net Truth Certainty Index ($C$) according to the formula:

$$C = S_{\text{base}} \times \left(1 + \alpha \cdot \log_{10}\left(\sum N\right)\right) - \beta \cdot \text{Risk}_{\text{cohort}} - \gamma \cdot \text{COI}_{\text{flag}}$$

wherein $S_{\text{base}}$ represents a baseline evidence rating, $\alpha$ is a sample size multiplier, $\beta$ is a trial design penalty, and $\gamma$ is a conflict-of-interest deduction.

### Claim 3: Real-Time Sensitivity Parameter Re-Weighting
A graphical user interface component configured to receive user adjustments to minimum sample size ($N$), publication recency, and peer-review filtering, and dynamically re-computing said Certainty Index in real time without requiring re-execution of the primary database query.

---

## 4. SYSTEM ARCHITECTURE & FLOW DIAGRAM

```
 [ USER INPUT HYPOTHESIS ]
            │
            ▼
┌─────────────────────────┐
│ Database Connector      │ ◄─── PubMed / CrossRef REST APIs
└───────────┬─────────────┘
            │
            ├──────────────────────────┐
            ▼                          ▼
┌───────────────────────┐   ┌───────────────────────┐
│ PROPONENT AGENT       │   │ SKEPTIC AGENT         │
│ Evaluates $p$-values, │   │ Scans COIs, sample    │
│ effect sizes, $N$     │   │ size limits, bias     │
└───────────┬───────────┘   └───────────┬───────────┘
            │                          │
            └─────────────┬────────────┘
                          ▼
             ┌───────────────────────────┐
             │ SYNTHESIZER AGENT         │
             │ Calculates GRADE Score %  │
             └────────────┬──────────────┘
                          ▼
             [ INTERACTIVE DOSSIER ]
```

---

## 5. INDUSTRIAL APPLICABILITY
The invention is applicable to biomedical research, clinical trial auditing, patent law due diligence, quantitative equity research, and enterprise risk management.
